On Nov. 5, Massachusetts could follow Oregon and Colorado in legalizing certain plant-based psychedelic drugs. However, experts urge caution regarding the safety and purity of such substances.
The proposed legislation, Massachusetts’ Question 4: The Natural Psychedelic Substances Act, would establish regulated access to natural psychedelic substances “that show therapeutic potential in increasing well-being and life satisfaction and improving mental health” at licensed therapy centers. If voted into law, Massachusetts residents 21 years and older would be able to legally purchase psilocybin (the active ingredient in so-called magic mushrooms), as well as other plant-based psychedelics, including psilocyn, dimethyltryptamine (DMT), mescaline and ibogaine.
A yes vote would set Massachusetts on a similar path to Oregon, which voted to legalize psilocybin in 2020, and Colorado, which in 2022 voted to decriminalize psilocybin, psilocyn, DMT, ibogaine and mescaline…